The FDA has approved J&J’s Covid-19 vaccine for emergency use, giving the U.S. a third tool to fight the pandemic.
Following the U.S Food and Drug Administration emergency use authorization for the Johnson & Johnson COVID-19 vaccine, Governor Brian Kemp issued the following statement:
“This single-dose, effective Johnson & Johnson COVID-19 vaccine will significantly increase the state’s ability to safely and efficiently vaccinate more Georgians,” said Governor Kemp. “The Georgia Department of Public Health expects that approximately 83,000 doses will be made available in the first week, and our goal is to get those vaccines administered as quickly as possible.”
The New York Times reported Saturday that “Johnson & Johnson has pledged to provide the United States with 100 million doses by the end of June. When combined with the 600 million doses from the two-shot vaccines made by Pfizer-BioNTech and Moderna slated to arrive by the end of July, there will be more than enough shots to cover any American adult who wants one.”
The vaccine, made by Janssen, J&J’s vaccine arm, is safe and effective, and it’s considered flexible. It’s a single dose, and it doesn’t require special storage, according to CNN.